Skip to main content Accessibility help
×
Home

Immunodiagnosis and molecular validation of Toxoplasma gondii infection among patients with end-stage renal disease undergoing haemodialysis

  • Zahra Arab-Mazar (a1) (a2), Shirzad Fallahi (a3) (a4), Davood Yadegarynia (a2), Amirreza Javadi Mamaghani (a5), Seyyed Javad Seyyed Tabaei (a2) (a5), Simin Rajaeian (a2) and Sara Rahmati Roodsari (a2)...

Abstract

Infection is a significant cause of morbidity and mortality in patients with chronic kidney disease, especially who were under dialysis due to their depressed immunity. Toxoplasma gondii is a ubiquitous parasite that causes severe manifestations in immunocompromised patients. This case-control study was conducted to the immunodiagnosis and molecular validation of T. gondii infection among patients with end-stage renal disease undergoing haemodialysis. The study population consisted of 260 haemodialysis patients and 259 healthy controls referred to the main dialysis centres of Tehran, Iran during 2016. Anti-T. gondii immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies were assessed using enzyme-linked immunosorbent assay. As well, the T. gondii genomic DNA in whole blood samples of IgM-positive patients and healthy controls was evaluated using GRA6-polymerase chain reaction (PCR) and SAG1-loop-mediated isothermal amplification (LAMP) assays. The anti-T. gondii IgG and IgM antibodies were detected in 175 (67.3%) and 18 (7%) of haemodialysis patients and 122 (47%) and 4 (1.5%) of controls, respectively. Two of the 18 blood samples from IgM-positive patients and none of the IgM-positive control subjects were positive by GRA6-PCR. Whereas, nine and two blood samples of IgM-positive patients and controls were positive for Toxoplasma DNA by a SAG1-LAMP technique respectively. The seropositivity of the Toxoplasma IgM antibody was significantly different between haemodialysis patients and healthy controls which was confirmed by PCR and LAMP. The higher prevalence of T. gondii infection in haemodialysis patients compared with the controls proposes that these patients can be a group at risk for toxoplasmosis and screening for toxoplasmosis before dialysis is necessary for the patients.

Copyright

Corresponding author

Author for correspondence: Seyyed Javad Seyyed Tabaei, E-mail: Seyyedtabaei@sbmu.ac.ir and Seyyedtabaei@gmail.com

References

Hide All
Al-Qurashi, A (2004) Seroepidemiological study of toxoplasmosis in rural areas in the eastern region of Saudi Arabia. Journal of the Egyptian Society of Parasitology 34, 2334.
Arab-Mazar, Z, Seyyed-Tabaei, SJ and Mirahmadi, H (2014) Cloning of dense granular (GRA) 7 gene of Toxoplasma gondii into pTZ57RT vectors for sub-cloning in prokaryotic and eukaryotic plasmids. Novelty in Biomedicine 2, 114119.
Arab-Mazar, Z, Fallahi, S, Koochaki, A, Haghighi, A and Tabaei, SJS (2016 a) Immunodiagnosis and molecular validation of Toxoplasma gondii-recombinant dense granular (GRA) 7 protein for the detection of toxoplasmosis in patients with cancer. Microbiological Research 183, 5359.
Arab-Mazar, Z, Zamanian, MH and Yadegarynia, D (2016 b) Cerebral toxoplasmosis in an HIV-negative patient: a case report. Archives of Clinical Infectious Diseases 11, 13.
Athlin, L and DomellÖF, L (1986) The phagocytic process of human peritoneal macrophages in cancer or uremia. Acta Pathologica Microbiologica Scandinavica Series C: Immunology 94, 6368.
Bahia-Oliveira, LMG, Jones, JL, Azevedo-Silva, J, Alves, CC, Oréfice, F and Addiss, DG (2003) Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil. Emerging Infectious Diseases 9, 55.
Daryani, A, Sarvi, S, Aarabi, M, Mizani, A, Ahmadpour, E, Shokri, A, Rahimi, M-T and Sharif, M (2014) Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. Acta Tropica 137, 185194.
Dubey, JP (2010) Toxoplasmosis of Animals and Humans. Boca Raton: CRC press.
Fallahi, S, Tabaei, SJS, Pournia, Y, Zebardast, N and Kazemi, B (2014) Comparison of loop-mediated isothermal amplification (LAMP) and nested-PCR assay targeting the RE and B1 gene for detection of Toxoplasma gondii in blood samples of children with leukaemia. Diagnostic Microbiology and Infectious Disease 79, 347354.
Fallahi, S, Mazar, ZA, Ghasemian, M and Haghighi, A (2015) Challenging loop—mediated isothermal amplification (LAMP) technique for molecular detection of Toxoplasma gondii. Asian Pacific Journal of Tropical Medicine 8, 366372.
Fallahi, S, Rostami, A, Birjandi, M, Zebardast, N, Kheirandish, F and Spotin, A (2017) Parkinson's disease and Toxoplasma gondii infection: sero-molecular assess the possible link among patients. Acta Tropica 173, 97101.
Ferreira, MS and Borges, AS (2002) Some aspects of protozoan infections in immunocompromised patients: a review. Memórias do Instituto Oswaldo Cruz 97, 443457.
Grassmann, A, Gioberge, S, Moeller, S and Brown, G (2005) ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrology Dialysis Transplantation 20, 25872593.
House, A (1987) Psychosocial problems of patients on the renal unit and their relation to treatment outcome. Journal of Psychosomatic Research 31, 441452.
Howe, DK and Sibley, LD (1995) Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. Journal of Infectious Diseases 172, 15611566.
Jones, JL, Dargelas, V, Roberts, J, Press, C, Remington, JS and Montoya, JG (2009) Risk factors for Toxoplasma gondii infection in the United States. Clinical Infectious Diseases 49, 878884.
Kato, S, Chmielewski, M, Honda, H, Pecoits-Filho, R, Matsuo, S, Yuzawa, Y, Tranaeus, A, Stenvinkel, P and Lindholm, B (2008) Aspects of immune dysfunction in end-stage renal disease. Clinical Journal of the American Society of Nephrology 3, 15261533.
Macpherson, CN (2005) Human behaviour and the epidemiology of parasitic zoonoses. International Journal for Parasitology 35, 13191331.
Mahmoudvand, H, Saedi Dezaki, E, Soleimani, S, Baneshi, M, Kheirandish, F, Ezatpour, B and Zia-ali, N (2015) Seroprevalence and risk factors of Toxoplasma gondii infection among healthy blood donors in south-east of Iran. Parasite Immunology 37, 362367.
Mori, Y, Nagamine, K, Tomita, N and Notomi, T (2001) Detection of loop-mediated isothermal amplification reaction by turbidity derived from magnesium pyrophosphate formation. Biochemical and Biophysical Research Communications 289, 150154.
Norouzi, M, Seyyed Tabaei, SJ, Niyyati, M, Saber, V and Behniafar, H (2016) Genotyping of Toxoplasma gondii strains isolated from patients with ocular toxoplasmosis in Iran. Iranian Journal of Parasitology 11, 316324.
Notomi, T, Okayama, H, Masubuchi, H, Yonekawa, T, Watanabe, K, Amino, N and Hase, T (2000) Loop-mediated isothermal amplification of DNA. Nucleic Acids Research 28, e63e63.
Ocak, S, Duran, N, Eskiocak, AF and Aytac, H (2005) Anti-Toxoplasma gondii antibodies in hemodialysis patients receiving long-term hemodialysis therapy in Turkey. Saudi Medical Journal 26, 13781382.
Omrani, VF, Fallahi, S, Rostami, A, Siyadatpanah, A, Barzgarpour, G, Mehravar, S, Memari, F, Hajialiani, F and Joneidi, Z (2015) Prevalence of intestinal parasite infections and associated clinical symptoms among patients with end-stage renal disease undergoing hemodialysis. Infection 43, 537544.
Petersen, E, Borobio, MV, Guy, E, Liesenfeld, O, Meroni, V, Naessens, A, Spranzi, E and Thulliez, P (2005) European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index. Journal of Clinical Microbiology 43, 15701574.
Rostami, A, Keshavarz, H, Shojaee, S, Mohebali, M and Meamar, AR (2014) Frequency of Toxoplasma gondii in HIV positive patients from West of Iran by ELISA and PCR. Iranian Journal of Parasitology 9, 474.
Rostami, A, Seyyedtabaei, SJ, Aghamolaie, S, Behniafar, H, Lasjerdi, Z, Abdolrasouli, A, Mehravar, S and Alvarado-Esquivel, C (2016) Seroprevalence and risk factors associated with Toxoplasma gondii infection among rural communities in Northern IRAN. Revista do Instituto de Medicina Tropical de São Paulo 58, 7077.
Rostami, A, Riahi, SM, Fakhri, Y, Saber, V, Hanifehpour, H, Valizadeh, S, Gholizadeh, M, Pouya, RH and Gamble, HR (2017) The global seroprevalence of Toxoplasma gondii among wild boars: a systematic review and meta-analysis. Veterinary Parasitology 244, 1220.
Shiadeh, MN, Niyyati, M, Fallahi, S and Rostami, A (2016 a) Human parasitic protozoan infection to infertility: a systematic review. Parasitology Research 115, 469477.
Shiadeh, MN, Rostami, A, Pearce, B, Gholipourmalekabadi, M, Newport, D, Danesh, M, Mehravar, S and Seyyedtabaei, S (2016 b) The correlation between Toxoplasma gondii infection and prenatal depression in pregnant women. European Journal of Clinical Microbiology & Infectious Diseases 35, 18291835.
Sibley, LD, Weidner, E and Krahenbuhl, JL (1985) Phagosome acidification blocked by intracellular Toxoplasma gondii. Nature 315, 416419.
Solhjoo, K, Jahromi, AS and Parnian-Rad, A (2010) Anti-Toxoplasma gondii antibodies in haemodialysis patients. American Journal of Infectious Diseases 6, 1317.
Szepietowski, JC, Reich, A and Pacan, P (2004) Psychodermatoses in haemodialysis patients. Dermatology 209, 344345.
Tonelli, M, Wiebe, N, Culleton, B, House, A, Rabbat, C, Fok, M, McAlister, F and Garg, AX (2006) Chronic kidney disease and mortality risk: a systematic review. Journal of the American Society of Nephrology 17, 20342047.
Vonesh, EF, Snyder, J, Foley, RN and Collins, AJ (2004) The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney International 66, 23892401.
Yazar, S, Demirtas, F, Yalcin, S, Yaman, O, Tokgoz, B, Utas, C and Sahin, I (2003 a) Anti-Toxoplasma gondii antibodies in haemodialysis patients with chronic renal failure. Yonsei Medical Journal 44, 288292.
Yazar, S, Demirtas, F, Yalcin, S, Yaman, O, Tokgoz, B, Utas, C and Sahin, I (2003 b) Anti-Toxoplasma gondii antibodies in haemodialysis patients with chronic renal failure. Yonsei Medical Journal 44, 288292.

Keywords

Immunodiagnosis and molecular validation of Toxoplasma gondii infection among patients with end-stage renal disease undergoing haemodialysis

  • Zahra Arab-Mazar (a1) (a2), Shirzad Fallahi (a3) (a4), Davood Yadegarynia (a2), Amirreza Javadi Mamaghani (a5), Seyyed Javad Seyyed Tabaei (a2) (a5), Simin Rajaeian (a2) and Sara Rahmati Roodsari (a2)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed